News & Events
2 November 2021
200th participant included!
We have now included our 200th participant in the EFFECT trial!
 READ MORE
28 October 2021
Thesis defense PREFERABLE colleague
Thursday (28th of October), our PREFERABLE colleague Anouk Hiensch successfully defended her thesis entitled 'Stepping stones to implement exercise as integral part of cancer care'.
 READ MORE
15 October 2021
6th PREFERABLE Consortium Meeting in San Sebastian
We finally met in person again during our 6th PREFERABLE Consortium Meeting in San Sebastian.
 READ MORE
Collaboration

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.